(Q45143413)
Statements
1 reference
Phase I study of dovitinib (TKI258), an oral FGFR, VEGFR, and PDGFR inhibitor, in advanced or metastatic renal cell carcinoma (English)
1 reference
1 reference
Bernard Escudier
1 reference
Jose A Lopez-Martin
1 reference
Chia-Chi Lin
1 reference
Jürgen E Gschwend
1 reference
Andrea Harzstark
1 reference
Daniel Castellano
1 reference
Paramita Sen
1 reference
Julie Chang
1 reference
Michael Shi
1 reference
Andrea Kay
1 reference
21 January 2013
1 reference
1 reference
Identifiers
1 reference